Taiwan-based SURGLASSES has closed an oversubscribed $6.5 million Pre-A funding round led by Taiwania Capital and followed by Integrated Capital, 500 STARTUPS V, L.P. from the United States, Wisdom Capital, and Sustainable Impact Capital (SIC).
The funds will primarily be used to accelerate the research, development, and promotion of SURGLASSES’s innovative Caduceus S AR navigation system, an FDA510(k) Clearance AR medical technology specially designed for complex spinal surgeries that allows real-time overlay of 3D spinal anatomy onto the patient during surgical procedures through multiple trackers and a transparent Head-Mounted Display (HMD), providing precise guidance and facilitating surgical operations for surgeons.
The Caduceus S system projects pre-planned trajectories onto the HMD, providing critical guidance to the surgeon without the need to shift focus to external monitors and ensuring a 100% field of view, allowing the surgeon to concentrate fully on the surgical procedure, ultimately increasing surgical precision. The seamless integration of the Caduceus S system not only enhances surgical precision, but also improves ergonomics and efficiency in the operating room.
We have a patent that enables precise navigation with only one C-arm. Compared to traditional navigation methods, our system exposes patients to less radiation during surgery, ensuring enhanced safety. We are poised to expedite market expansion in the United States,” said Miron Wang, the CEO of SURGLASSES.